Pediatric herpes zoster in an immunocompetent patient: a case report
Main Article Content
Keywords
Herpes Zoster, Pediatrics, Varicella-Zoster Virus, Child, Acyclovir
Abstract
Herpes zoster is a neurocutaneous infection caused by reactivation of the varicella-zoster virus and occurs more frequently in immunocompromised individuals. Its presentation in immunocompetent pediatric patients is uncommon, which may delay diagnosis. We report the case of a 7-year-old immunocompetent female patient with no relevant medical history who presented with a one-week history of dermatosis localized to the right hemithorax with extension to the ipsilateral axillary region, characterized by vesicular lesions on an erythematous base associated with burning pain. The diagnosis of herpes zoster was established based on clinical findings. Antiviral therapy with acyclovir was initiated, resulting in a favorable clinical course with complete resolution of lesions within four weeks and no complications or sequelae. This case highlights the importance of considering herpes zoster in the differential diagnosis of vesicular dermatoses in immunocompetent children, as early recognition and timely treatment are essential to prevent complications.
References
2. Calabrese C, Kirchner E, Fernandez J, Calabrese LH. Preventing herpes zoster in immunocompromised patients: current concepts. Cleve Clin J Med. 2024;91(7):437–45.
3. Giannelos N, Curran D, Nguyen C, Kagia C, Vroom N, Vroling H. The incidence of herpes zoster complications: a systematic literature review. Infect Dis Ther. 2024;13(7):1461–86.
4. Lewandowski D, Toczylowski K, Kowalska M, Krasnodębska M, Krupienko I, Nartowicz K, et al. Varicella-zoster disease of the central nervous system in immunocompetent children: case series and a scoping review. Vaccines (Basel). 2024;12(9):1086.
5. MacDonald J, Mosser-Goldfarb J, Souverbielle CT, Cuff S. An unusual case of arm pain in a young soccer player: herpes zoster in the pediatric athlete. Curr Sports Med Rep. 2022;21(11):386–90.
6. Arce M, Paullier F, Notejane M, González V. Características epidemiológicas, clínicas y evolutivas de niños hospitalizados por herpes zóster en un centro de referencia de Uruguay (2008–2019). Arch Pediatr Urug. 2020;91(3):139–46.
7. Shang BS, Hung CJ, Lue KH. Herpes zoster in an immunocompetent child without a history of varicella. Pediatr Rep. 2021;13(2):162–7.
8. Dei-Cas PG, Dei-Cas IJ, Rodolfo NR. Herpes zóster diseminado en un niño sano. Rev Cubana Pediatr. 2024;96:e5446.
9. Ehrenstein B. Diagnosis, treatment and prophylaxis of herpes zoster. Z Rheumatol. 2020;79(10):1009–17.
10. Kang DH, Kwak BO, Park AY, Kim HW. Clinical manifestations of herpes zoster associated with complications in children. Children (Basel). 2021;8(10):845.
11. Hakim FE, Riaz K, Farooq A. Pediatric herpes zoster ophthalmicus: a systematic review. Graefes Arch Clin Exp Ophthalmol. 2023;261(8):2169–79.
12. Kuş MM, Taşolar MK, Kuş C, Öztürk P, Nazik H, Mülayim MK. Herpes zoster in children: a retrospective evaluation of 128 cases. Indian J Paediatr Dermatol. 2023;24:228–31.
13. Muñoz-Estrada VF, Osuna-Leal ÁI, Estrada-Alpízar L. Estudio clínico de herpes zóster en niños. Rev Med UAS. 2022;12(4):289–98.
14. Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(1):192.
15. Sabido-Toledo L, Martínez-García G, Simón-Rodríguez I. Herpes zóster en lactantes: presentación de tres casos. Rev Med Electron. 2021;43(5).
16. Alhwayan AA, Alsallal A, Njadat M, Alhammad M, Haddadin B. Intravenous immunoglobulin and intravenous acyclovir as an alternative therapy to varicella-zoster immunoglobulin in the prevention of serious complications of neonatal varicella. Cureus. 2024;16(6):e63515.
17. Forer E, Yariv A, Ostrovsky D, Horev A. The association between varicella vaccination and herpes zoster in children: a semi-national retrospective study. J Clin Med. 2023;12(13):4294.
18. Helali HA, Saeed AA, Waleed A, Nath JR, Alhammadi M. Successful treatment of a rare complication of varicella pneumonitis in an immunocompromised 11-year-old child using pooled intravenous immunoglobulin. Cureus. 2024;16(10):e71582.
19. Hasipi M, Topuzovska IK, Cvetanovska M, Bozhinoski H. Herpes zoster in a 5-year-old girl with no previous history of chickenpox: a case report. Acad Med J. 2024;4(3):139–47.
20. Jiménez Alés R, García Gestoso ML. Varicela y herpes zóster. In: Infecciones en Pediatría. Guía rápida para la selección del tratamiento antimicrobiano empírico (Guía-ABE). 2023;4.1.
21. Gadimova A, Arga G, Taşkın EÇ, Konca HK, Özdemir H, Çakmaklı HF, et al. Evaluation of paediatric herpes zoster cases: comparison of herpes zoster attacks in children with and without underlying conditions. J Paediatr Child Health. 2024;60(12):825–30.
22. Latif TM. Herpes zoster in children: a prospective study. J Pak Assoc Dermatol. 2023;33(3):813–6.
23. Dayan RR, Peleg R. Herpes zoster: typical and atypical presentations. Postgrad Med. 2017;129(6):567–71.
24. Kotto R, Sigha OB, Nkoro GA, Nida M, Meledie AP, Kouotou EA, et al. Varicella-zoster virus and its puzzles in infants. Health Sci Dis. 2025;26(2).
25. Molero JM, Ortega J, Montoro I, McCormick N. Estado actual del herpes zóster y nuevas perspectivas para su prevención. Vacunas. 2024;25(2):254–63.
26. Torres Ordoñez G, Bastard D, Torre AC. Herpes zóster: actualización y manejo. Dermatol Argent. 2021;27(2):44–52.
27. Vogel C, Wetzel L, Wutzler P, Gruhn B. Treatment with brivudine in immunocompromised pediatric patients with herpes zoster. Chemotherapy. 2023;68(4):222–7. doi:10.1159/000531034.
28. Willoughby SL, Burton P, Carroll JR. Herpes zoster in a 13-year-old male without prior varicella infection. Cureus. 2024;16(5):e61155. doi:10.7759/cureus.61155.
29. Vargas-Mosso ME, Fraga-Pérez J, Reyes-Gómez U, Virgen-Ortega C, Guerrero-Becerra M, Reyes-Hernández KL, et al. Vacuna contra la varicela: su importancia. Sal Jal. 2024;11(3):152–8. doi:10.35366/115749.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
RHCS uses the Creative Commons License 4.0 International (CC BY 4.0). For more information, please visit
MD Katia Aguilar-Gutiérrez, Faculty of Medical Sciences, Universidad Nacional Autónoma de Honduras (UNAH), Tegucigalpa, Honduras
Médico, Especialista en Dermatología